Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs LyondellBasell Industries NV (LYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs LyondellBasell Industries NV — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while LyondellBasell Industries NV trades at $61.17 (market cap $19.39B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and LyondellBasell Industries NV pays the higher dividend (4.6%). Which is the better fit depends on your goals.
| GEHC | LYB | |
|---|---|---|
Market Cap | $31.07B | $19.39B |
Volume | 3,443,020 | 3,160,509 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $82.38 |
52-Week Low | $59.48 | $42.28 |
Enterprise Value | $39.53B | $30.98B |
Dividend Yield | 0.23% | 4.6% |
Typical Hold Time | — | 88 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
LyondellBasell (LYB) trades at $61.17, up 2.96% today, with a mixed technical picture showing bearish moving averages but neutral oscillators. Fundamentally, the company reported a net loss of $745 million in 2025, with revenue declining to $30.15 billion, though recent quarters have beaten EPS estimates. Analyst sentiment is balanced with a 45% buy and 45% hold rating, and a consensus price target of $68.56 suggests modest upside. The dividend yield remains a key focus amid sector challenges.
The outlook for LYB hinges on earnings recovery and dividend sustainability. Opportunities include operational leverage and favorable market conditions, but risks involve persistent negative margins, high debt levels, and competitive pressures. The stock's performance will likely depend on reversing profitability trends and maintaining investor confidence through consistent dividend payments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →
